Healthcare
Quick-Med Technologies, Inc.(QMDT)
Live Price
Offline$0.0008
+0.00% today
1Y Change
+700.00%
Window
Jun 23, 2025 → Jun 17, 2026
- Market Cap
- —
- Revenue Growth
- -6.9%
- EPS Growth
- +57.7%
- Dividend Yield
- 0.0%
Coverage: 251 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Quick-Med Technologies, Inc. (QMDT) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 700.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -6.9%, EPS growth of +57.7%, a dividend yield of 0.0%. What stands out right now is revenue -6.9%, EPS +57.7%, free cash flow +99.9% with operating margin -40.5% and ROIC -974.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines QMDT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-6.9% vs +7.6% peer median
Operating Margin
Below sector median
-40.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -6.9% and EPS is at +57.7%, with operating margin around -40.5%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QMDT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
QMDT Max Drawdown
-25.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for QMDT and SPY.
Company Overview
Quick-Med Technologies, Inc.
Other OTC
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company's core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.
- Leadership
- Gregory S. Schultz
- IPO Date
- Oct 16, 2002
- Employees
- 5
- Street Address
- 902 NW 4th Street
- Mailing
- Gainesville, FL, 32601
- Region
- Gainesville, FL, US
- Reporting Currency
- USD
- Investor Line
- 352-379-0611
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.0
- Price/Book
- —
Growth
- Revenue
- -6.9%
- EPS
- +57.7%
- Free Cash Flow
- +99.9%
Profitability
- Gross Margin
- 69.8%
- Operating Margin
- -40.5%
- Net Margin
- -76.8%
- ROE
- 8.3%
- ROIC
- -974.6%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.03
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.